Kwality Pharmaceuticals Limited (BOM:539997)
India
· Delayed Price · Currency is INR 1,492.95
+42.20 (2.91%)
At close: Mar 9, 2026
Kwality Pharmaceuticals Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 15,491 | 9,017 | 4,248 | 3,191 | 6,018 | 581 | Upgrade
|
| Market Cap Growth | 90.52% | 112.27% | 33.12% | -46.97% | 935.71% | 119.18% | Upgrade
|
| Enterprise Value | 16,238 | 9,948 | 5,076 | 4,145 | 6,180 | 772 | Upgrade
|
| Last Close Price | 1492.95 | 869.05 | 409.40 | 307.55 | 580.00 | 56.00 | Upgrade
|
| PE Ratio | 27.43 | 22.63 | 17.85 | 16.47 | 5.02 | 3.84 | Upgrade
|
| PS Ratio | 3.36 | 2.44 | 1.38 | 1.27 | 1.32 | 0.22 | Upgrade
|
| PB Ratio | 5.37 | 3.44 | 1.91 | 1.60 | 3.35 | 0.97 | Upgrade
|
| P/TBV Ratio | 5.37 | 3.44 | 1.90 | 1.59 | 3.32 | 0.95 | Upgrade
|
| P/FCF Ratio | - | 30.65 | 32.33 | - | 110.54 | 17.58 | Upgrade
|
| P/OCF Ratio | - | 17.11 | 9.88 | 7.71 | 9.93 | 2.18 | Upgrade
|
| EV/Sales Ratio | 3.52 | 2.69 | 1.65 | 1.65 | 1.36 | 0.29 | Upgrade
|
| EV/EBITDA Ratio | 15.41 | 12.13 | 7.46 | 6.73 | 3.56 | 2.56 | Upgrade
|
| EV/EBIT Ratio | 18.45 | 15.61 | 10.48 | 8.88 | 3.80 | 3.26 | Upgrade
|
| EV/FCF Ratio | - | 33.81 | 38.62 | - | 113.51 | 23.35 | Upgrade
|
| Debt / Equity Ratio | 0.38 | 0.43 | 0.44 | 0.45 | 0.35 | 0.69 | Upgrade
|
| Debt / EBITDA Ratio | 1.05 | 1.37 | 1.44 | 1.46 | 0.36 | 1.37 | Upgrade
|
| Debt / FCF Ratio | - | 3.82 | 7.47 | - | 11.61 | 12.47 | Upgrade
|
| Net Debt / Equity Ratio | 0.27 | 0.37 | 0.41 | 0.42 | 0.28 | 0.52 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.73 | 1.19 | 1.36 | 1.35 | 0.29 | 1.03 | Upgrade
|
| Net Debt / FCF Ratio | - | 3.32 | 7.01 | -13.18 | 9.23 | 9.37 | Upgrade
|
| Asset Turnover | - | 0.88 | 0.82 | 0.72 | 1.80 | 1.76 | Upgrade
|
| Inventory Turnover | - | 2.33 | 1.92 | 1.63 | 4.88 | 5.75 | Upgrade
|
| Quick Ratio | - | 1.07 | 0.90 | 0.68 | 0.65 | 0.59 | Upgrade
|
| Current Ratio | - | 1.67 | 1.60 | 1.65 | 1.63 | 1.35 | Upgrade
|
| Return on Equity (ROE) | - | 16.41% | 11.20% | 10.18% | 100.10% | 28.41% | Upgrade
|
| Return on Assets (ROA) | - | 9.47% | 8.10% | 8.40% | 40.13% | 9.90% | Upgrade
|
| Return on Invested Capital (ROIC) | 17.73% | 13.89% | 12.33% | 13.75% | 75.28% | 19.99% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 23.00% | 20.00% | 20.50% | 80.90% | 26.90% | Upgrade
|
| Earnings Yield | 3.65% | 4.42% | 5.60% | 6.07% | 19.94% | 26.07% | Upgrade
|
| FCF Yield | - | 3.26% | 3.09% | -1.97% | 0.91% | 5.69% | Upgrade
|
| Buyback Yield / Dilution | -0.77% | - | - | - | -0.00% | - | Upgrade
|
| Total Shareholder Return | -0.77% | - | - | - | -0.00% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.